Showing results (21-30 of 237) with videos related to
Sort By:
Pageof 24
Prostaglandins, Leukotrienes, and Essential Fatty Acids|October 1, 1989
BM 13.505, a selective thromboxane receptor antagonist, reduces myocardial infarct size following coronary artery reperfusionE F Smith, C Q Earl, J W EganFASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 1, 1991
Priming interactions between platelet activating factor and histamine in the in vivo microcirculationA C Tomeo, R W Egan, W N DuránPharmacology|January 1, 1989
Effect of propranolol on ischemic myocardial damage and left ventricular hypertrophy following permanent coronary artery occlusion or occlusion followed by reperfusionE F Smith, J W Egan, D E GriswoldBlood|June 1, 1984
Control of oxygen affinity of hemoglobin in K562 cells induced by heminY Wu, A Dean, W Egan, et al.Agents and Actions|March 1, 1990
Naphthalenes as inhibitors of myeloperoxidase: direct and indirect mechanisms of inhibitionR W Egan, W K Hagmann, P H GaleBiochemistry|May 30, 1978
Differential effects of prostaglandin synthetase stimulators on inhibition of cyclooxygenaseR W Egan, J L Humes, F A KuehlGene|October 7, 2003
Identification and characterization of a new human type 9 cGMP-specific phosphodiesterase splice variant (PDE9A5). Differential tissue distribution and subcellular localization of PDE9A variantsPeng Wang, Ping Wu, Robert W Egan, et al.Biochemical and Biophysical Research Communications|October 12, 2000
Cloning, characterization, and tissue distribution of mouse phosphodiesterase 7A1P Wang, P Wu, R W Egan, et al.Pharmacology|January 1, 1991
Identification of cardiac endothelin binding sites in rats: downregulation of left atrial endothelin binding sites in response to myocardial infarctionP Nambi, M Pullen, J W Egan, et al.European Journal of Pharmacology|January 7, 1992
High affinity histamine H3 receptors regulate ACTH release by AtT-20 cellsM A Clark, A Korte, J Myers, et al.Pageof 24